NEW YORK (GenomeWeb) – Sophia Genetics announced today that its Hereditary Cancer Solution has received CE-IVD certification.

The genetic screen uses Integrated DNA Technologies' xGen Lockdown Probes to look at 27 genes relevant to breast, ovarian, and gastrointestinal hereditary cancers and includes specialized analytics developed by Sophia. The CE Mark applies to the combination of target capture technology and analytics, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Feb
27

In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep. 

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.